Oasis in the news

Any examples of strategies, trade ideas, or case studies are intended for illustrative and discussion purposes only, and are not necessarily indicative of the historical or future strategy or performance or the chances of success of any particular strategy. There can be no assurance that investment opportunities described herein will become available in the future. It should not be assumed that any investments described by any models would be profitable if implemented because among other things, assumptions described herein may not materialize. Any specific investments or case studies referenced in this presentation were selected for inclusion herein based on objective, non-performance based criteria solely for the purpose of describing the investment processes and analyses used by Oasis to evaluate such investments. A list of historical investments – including investments that lost money — can be made available upon request. As always, past performance is not necessarily indicative of future results.

21

March 2024

Special Report: Legal battle with shareholders awaits; Taisho Pharmaceutical HD – Hopes placed on activists (summary translation)

Nihon Securities Journal

Read Story

21

March 2024

Kumagai Gumi reaches 18-year high amid enlarged stake by Oasis (summary translation)

Kabushiki Shimbun

Read Story

19

March 2024

March AGM season is in full swing: Focus is on activist-owned stocks (summary translation)

Nihon Securities Journal

Read Story

18

March 2024

Investment fund Oasis raises stake in Kumagai Gumi, where it made shareholder proposals last year (summary translation)

cReuters Japan

Read Story

15

March 2024

Activist investor Oasis builds stake in sandwich maker Greencore

Financial Times

Read Story

13

March 2024

Oasis files petition regarding pricing of [CTC] shares in relation to Itochu’s acquisition of CTC as wholly owned subsidiary (summary translation)

The Nikkei

Read Story

12

March 2024

Predicting the stock prices of ‘[cash] rich’ companies: Will the companies hoarding 18 trillion yen in cash begin to use that money toward growth investments? (summary translation)

The Nikkei

Read Story

11

March 2024

Tsuruha to become part of Aeon: The ripple effect of the ‘2-trillion-yen drug alliance’ – Aeon worked quickly and will acquire investment fund’s entire stake (summary translation)

Toyo Keizai

Read Story

11

March 2024

Hong Kong-based investment fund Oasis targets Tsuruha, Japan’s second largest drugstore, and Ain, the leading dispensing pharmacy operator (summary translation)

M&A Online

Read Story

08

March 2024

Activist fund Oasis says it may take legal action over Taisho’s management buyout

Reuters

Read Story

08

March 2024

Ain Holdings share price soars following reveal of activist investor’s increased stake: Potential for industry restructuring seen positively? (summary translation)

Hokkaido Shimbun

Read Story

07

March 2024

Oasis Management CIO says company ‘will consider all possible options’ regarding [possible] completion of Taisho Pharmaceutical MBO (full translation)

Bloomberg

Read Story

06

March 2024

Oasis owns significant 9.60% stake in drugstore operator Ain HD (summary translation)

Reuters Japan

Read Story

06

March 2024

Hong Kong fund acquires large stake in dispensing pharmacy operator Ain HD and ‘may make important proposals’ (summary translation)

Yomiuri Shimbun

Read Story

04

March 2024

Oasis Management CIO remains ‘very bullish’ on Japan, says there is plenty of room for more M&A deals (summary translation)

Bloomberg

Read Story

04

March 2024

Japan Ahead: Oasis Management’s Fischer Remains ‘Very Bullish’ on Stocks

Bloomberg TV

Read Story

29

February 2024

Aeon embarks on industry restructuring: A 10-trillion-yen company at last, Aeon has succeeded in cajoling Tsuruha and Welcia into a merger

The Nikkei

Read Story

29

February 2024

JAE completes tender offer for its own shares; NEC applied even amid shareholder objection

The Nikkei

Read Story

29

February 2024

Tsuruha and Welcia to merge by 2027, led by Aeon

The Nikkei

Read Story

29

February 2024

Aeon’s long-held dream of conducting a major drugstore industry reorganization under the banner of fostering ‘global companies’

The Nikkei

Read Story

29

February 2024

Welcia-Tsuruha merger sparks drugstore industry reorganization: A major alliance worth 2 trillion yen in [annual] sales is born

Yomiuri Shimbun

Read Story

29

February 2024

Tsuruha Holdings to become part of Aeon and merge with Welcia Holdings by end of 2027

Hokkaido Shimbun

Read Story

29

February 2024

Competition Intensifies: Restructuring looms closer – Tsuruha to become part of Aeon – Trigger for talks with ‘activist shareholder’

Hokkaido Shimbun

Read Story

28

February 2024

JAE share price down by 3% due to continued selling following the rejection of Oasis’ injunction over soon-to-expire tender offer

Nikkei QUICK News

Read Story

28

February 2024

Japan retailer Aeon to merge with drugstore chains Tsuruha and Welcia

Reuters

Read Story

27

February 2024

Hazama Ando tops expected dividends ranking despite decrease in net profit – Financial Results Ranking (#2): Expected dividend yields for the fiscal year ending March 31, 2024

The Nikkei

Read Story

27

February 2024

The Present and Future of Governance – Tokyo Disney operator’s shares targeted again; Mitsui Fudosan invests as part of its ‘core business’

Nikkei Business

Read Story

26

February 2024

Fund files injunction against NEC’s sale of subsidiary shares

The Nikkei

Read Story

26

February 2024

Tsuruha HD shares temporarily up 14% on possibility of merger with Welcia HD

The Nikkei

Read Story

26

February 2024

Hong Kong investor files court injunction on NEC’s JAE stake sale

Reuters

Read Story
error: Content is protected !!